Emeryville, CA, United States of America

John Darren Campbell


Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: The Innovative Contributions of John Campbell in Vaccine Development

Introduction

John Campbell, an inventive mind based in Emeryville, CA, has made significant strides in the field of vaccine development. As an inventor with a focus on addressing global health challenges, his contributions are noteworthy, particularly in the fight against SARS-CoV-2.

Latest Patents

John Campbell holds one patent, which focuses on the development of CpG-adjuvanted SARS-CoV-2 vaccines. This patent describes compositions and methods for producing and administering these vaccines to individuals in need, highlighting innovative approaches to enhancing immune responses against the virus.

Career Highlights

Throughout his career, John has worked with prominent companies in the biotechnology sector. He has contributed his expertise at Valneva Austria GmbH and Dynavax Technologies Corporation, both of which are known for their advancements in vaccine technology and therapeutic solutions.

Collaborations

In his professional journey, John has collaborated with skilled individuals, including his coworkers Andreas Meinke and Michael Möhlen. Their combined efforts contribute to the innovation and efficiency in vaccine research and development.

Conclusion

John Campbell’s work exemplifies the crucial role of inventors in enhancing public health through innovative solutions like vaccines. His dedication to research and collaboration continues to drive advancements in the fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…